• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
The 2009-2014 World Outlook for Veterinary Pharmaceutical Preparations of Intravenous Solutions and Electrolytes - Product Image

The 2009-2014 World Outlook for Veterinary Pharmaceutical Preparations of Intravenous Solutions and Electrolytes

  • ID: 679315
  • September 2008
  • Region: Global
  • 197 pages
  • ICON Group International

WHAT IS LATENT DEMAND AND THE P.I.E.?

The concept of latent demand is rather subtle. The term latent typically refers to something that is dormant, not observable, or not yet realized. Demand is the notion of an economic quantity that a target population or market requires under different assumptions of price, quality, and distribution, among other factors. Latent demand, therefore, is commonly defined by economists as the industry earnings of a market when that market becomes accessible and attractive to serve by competing firms. It is a measure, therefore, of potential industry earnings (P.I.E.) or total revenues (not profit) if a market is served in an efficient manner. It is typically expressed as the total revenues potentially extracted by firms. The “market” is defined at a given level in the value chain. There can be latent demand at the retail level, at the wholesale level, the manufacturing level, and the raw materials level (the P.I.E. of higher levels of the value chain being always smaller than the P.I.E. of levels at lower levels of the same value chain, assuming all levels maintain minimum profitability).

The latent demand for veterinary pharmaceutical READ MORE >

1 INTRODUCTION 10
1.1 Overview 10
1.2 What is Latent Demand and the P.I.E.? 10
1.3 The Methodology 11
1.3.1 Step 1. Product Definition and Data Collection 12
1.3.2 Step 2. Filtering and Smoothing 13
1.3.3 Step 3. Filling in Missing Values 13
1.3.4 Step 4. Varying Parameter, Non-linear Estimation 14
1.3.5 Step 5. Fixed-Parameter Linear Estimation 14
1.3.6 Step 6. Aggregation and Benchmarking 15
1.3.7 Step 7. Latent Demand Density: Allocating Across Cities 15
2 SUMMARY OF FINDINGS 16
2.1 The Worldwide Market Potential 16
3 AFRICA 18
3.1 Executive Summary 18
3.2 Algeria 19
3.3 Angola 20
3.4 Benin 21
3.5 Botswana 21
3.6 Burkina Faso 22
3.7 Burundi 23
3.8 Cameroon 24
3.9 Cape Verde 25
3.10 Central African Republic 25
3.11 Chad 26
3.12 Comoros 27
3.13 Congo (formerly Zaire) 27
3.14 Cote dIvoire 28
3.15 Djibouti 29
3.16 Egypt 30
3.17 Equatorial Guinea 31
3.18 Ethiopia 31
3.19 Gabon 32
3.20 Ghana 33
3.21 Guinea 34
3.22 Guinea-Bissau 34
3.23 Kenya 35
3.24 Lesotho 36
3.25 Liberia 36
3.26 Libya 37
3.27 Madagascar 38
3.28 Malawi 38
3.29 Mali 39
3.30 Mauritania 40
3.31 Mauritius 40
3.32 Morocco 41
3.33 Mozambique 42
3.34 Namibia 42
3.35 Niger 43
3.36 Nigeria 44
3.37 Republic of Congo 45
3.38 Reunion 45
3.39 Rwanda 46
3.40 Sao Tome E Principe 47
3.41 Senegal 47
3.42 Sierra Leone 48
3.43 Somalia 49
3.44 South Africa 50
3.45 Sudan 51
3.46 Swaziland 51
3.47 Tanzania 52
3.48 The Gambia 53
3.49 Togo 54
3.50 Tunisia 55
3.51 Uganda 56
3.52 Western Sahara 56
3.53 Zambia 57
3.54 Zimbabwe 58
4 ASIA & OCEANA 59
4.1 Executive Summary 59
4.2 American Samoa 60
4.3 Australia 61
4.4 Bangladesh 62
4.5 Bhutan 63
4.6 Brunei 63
4.7 Burma 64
4.8 Cambodia 65
4.9 China 65
4.10 Christmas Island 66
4.11 Cook Islands 67
4.12 Fiji 67
4.13 French Polynesia 68
4.14 Guam 69
4.15 Hong Kong 69
4.16 India 70
4.17 Indonesia 71
4.18 Japan 72
4.19 Kiribati 73
4.20 Laos 73
4.21 Macau 74
4.22 Malaysia 75
4.23 Maldives 76
4.24 Marshall Islands 76
4.25 Micronesia Federation 77
4.26 Mongolia 78
4.27 Nauru 78
4.28 Nepal 79
4.29 New Caledonia 80
4.30 New Zealand 80
4.31 Niue 81
4.32 Norfolk Island 82
4.33 North Korea 82
4.34 Palau 83
4.35 Papua New Guinea 84
4.36 Philippines 84
4.37 Seychelles 85
4.38 Singapore 86
4.39 Solomon Islands 87
4.40 South Korea 87
4.41 Sri Lanka 88
4.42 Taiwan 89
4.43 Thailand 90
4.44 The Northern Mariana Island 91
4.45 Tokelau 92
4.46 Tonga 92
4.47 Tuvalu 93
4.48 Vanuatu 94
4.49 Vietnam 94
4.50 Wallis and Futuna 95
4.51 Western Samoa 96
5 EUROPE 97
5.1 Executive Summary 97
5.2 Albania 98
5.3 Andorra 99
5.4 Austria 100
5.5 Belarus 101
5.6 Belgium 102
5.7 Bosnia and Herzegovina 103
5.8 Bulgaria 103
5.9 Croatia 104
5.10 Cyprus 105
5.11 Czech Republic 105
5.12 Denmark 106
5.13 Estonia 107
5.14 Finland 108
5.15 France 109
5.16 Georgia 110
5.17 Germany 111
5.18 Greece 112
5.19 Hungary 113
5.20 Iceland 114
5.21 Ireland 115
5.22 Italy 115
5.23 Kazakhstan 116
5.24 Latvia 117
5.25 Liechtenstein 118
5.26 Lithuania 119
5.27 Luxembourg 119
5.28 Malta 120
5.29 Moldova 121
5.30 Monaco 121
5.31 Norway 122
5.32 Poland 123
5.33 Portugal 124
5.34 Romania 125
5.35 Russia 126
5.36 San Marino 127
5.37 Slovakia 127
5.38 Slovenia 128
5.39 Spain 129
5.40 Sweden 130
5.41 Switzerland 131
5.42 The Netherlands 132
5.43 The United Kingdom 133
5.44 Ukraine 134
6 LATIN AMERICA 135
6.1 Executive Summary 135
6.2 Argentina 136
6.3 Belize 137
6.4 Bolivia 138
6.5 Brazil 139
6.6 Chile 140
6.7 Colombia 141
6.8 Costa Rica 142
6.9 Ecuador 142
6.10 El Salvador 143
6.11 French Guiana 144
6.12 Guatemala 144
6.13 Guyana 145
6.14 Honduras 146
6.15 Mexico 147
6.16 Nicaragua 148
6.17 Panama 149
6.18 Paraguay 150
6.19 Peru 151
6.20 Suriname 152
6.21 The Falkland Islands 152
6.22 Uruguay 153
6.23 Venezuela 154
7 NORTH AMERICA & THE CARIBBEAN 155
7.1 Executive Summary 155
7.2 Antigua and Barbuda 156
7.3 Aruba 157
7.4 Barbados 158
7.5 Bermuda 158
7.6 Canada 159
7.7 Cuba 160
7.8 Dominica 161
7.9 Dominican Republic 161
7.10 Greenland 162
7.11 Grenada 163
7.12 Guadeloupe 164
7.13 Haiti 165
7.14 Jamaica 165
7.15 Martinique 166
7.16 Puerto Rico 167
7.17 St. Kitts and Nevis 168
7.18 St. Lucia 168
7.19 St. Vincent and the Grenadines 169
7.20 The Bahamas 170
7.21 The British Virgin Islands 170
7.22 The Cayman Islands 171
7.23 The Netherlands Antilles 172
7.24 The U.S. Virgin Islands 172
7.25 The United States 173
7.26 Trinidad and Tobago 174
8 THE MIDDLE EAST 176
8.1 Executive Summary 176
8.2 Afghanistan 177
8.3 Armenia 178
8.4 Azerbaijan 179
8.5 Bahrain 180
8.6 Iran 181
8.7 Iraq 182
8.8 Israel 183
8.9 Jordan 183
8.10 Kuwait 184
8.11 Kyrgyzstan 185
8.12 Lebanon 185
8.13 Oman 186
8.14 Pakistan 187
8.15 Palestine 188
8.16 Qatar 188
8.17 Saudi Arabia 189
8.18 Syrian Arab Republic 190
8.19 Tajikistan 191
8.20 The United Arab Emirates 191
8.21 Turkey 192
8.22 Turkmenistan 193
8.23 Uzbekistan 193
8.24 Yemen 194
9 DISCLAIMERS, WARRANTEES, AND USER AGREEMENT PROVISIONS 196
9.1 Disclaimers & Safe Harbor 196
9.2 ICON Group International, Inc. User Agreement Provisions 197

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos